Back to News
Market Impact: 0.15
CVRx Appoints As John Landry CFO
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
CVRx appointed John Landry as chief financial officer, effective October 12. He succeeds John Oasheim, who will remain with the medical-device company for a transition period; the announcement does not disclose a financial outlook change or operating impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
CVRX0.15
More News
- Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
- RIP the Cybertruck: Elon Musk says Tesla will wind down production of its most polarizing EV
- Globus Medical stock holds at Neutral as BTIG cites revenue miss
- South Korean corporate reforms hit rough patch as Samsung digs in
- Canaccord reiterates Natera stock rating on strong Q3 results
- BMO Capital downgrades Strategic Education stock rating on enrollment declines